[ET Net News Agency, 11 April 2024] CCB International lowered the target price for Ali
Health (00241) to HKD4.2 from HKD6.3 and maintained the "outperform" rating.
The research house said it lowers FY24F top line forecast by 16.4% but increases
adjusted net profit forecast by 96.8% to account for higher interest income and net profit
contribution from the Alimama acquisition. (rc)